nsv930791
- Organism: Homo sapiens
- Study:nstd36 (Mitsui et al. 2010)
- Variant Type:copy number variation
- Method Type:Oligo aCGH, Sequencing
- Submitted on:NCBI36 (hg18)
- Variant Calls:2
- Validation:Not tested
- Clinical Assertions: Yes
- Region Size:198,651
- Publication(s):Mitsui et al. 2010
Source: NCBI
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 2406 SVs from 98 studies. See in: genome view
Overlapping variant regions from other studies: 2406 SVs from 98 studies. See in: genome view
Overlapping variant regions from other studies: 650 SVs from 28 studies. See in: genome view
Variant Region Placement Information
| Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Start | Stop |
|---|---|---|---|---|---|---|---|---|---|
| nsv930791 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000006.12 | Chr6 | 162,296,325 | 162,494,975 |
| nsv930791 | Remapped | Perfect | GRCh37.p13 | Primary Assembly | First Pass | NC_000006.11 | Chr6 | 162,717,357 | 162,916,007 |
| nsv930791 | Submitted genomic | NCBI36 (hg18) | Primary Assembly | NC_000006.10 | Chr6 | 162,637,347 | 162,835,997 |
Variant Call Information
| Variant Call ID | Type | Method | Analysis | Subject Phenotype | Clinical Interpretation | Source of Interpretation |
|---|---|---|---|---|---|---|
| nssv649985 | duplication | Oligo aCGH, Sequencing | Probe signal intensity, Sequence alignment | Parkinsonian Disorders | Pathogenic | Submitter |
| nssv650309 | duplication | Oligo aCGH, Sequencing | Probe signal intensity, Sequence alignment | Neoplasms | Pathogenic | Submitter |
Variant Call Placement Information
| Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Start | Stop |
|---|---|---|---|---|---|---|---|---|---|
| nssv649985 | Remapped | Perfect | NC_000006.12:g.162 296325_162494975du p | GRCh38.p12 | First Pass | NC_000006.12 | Chr6 | 162,296,325 | 162,494,975 |
| nssv650309 | Remapped | Perfect | NC_000006.12:g.162 296325_162494975du p | GRCh38.p12 | First Pass | NC_000006.12 | Chr6 | 162,296,325 | 162,494,975 |
| nssv649985 | Remapped | Perfect | NC_000006.11:g.162 717357_162916007du p | GRCh37.p13 | First Pass | NC_000006.11 | Chr6 | 162,717,357 | 162,916,007 |
| nssv650309 | Remapped | Perfect | NC_000006.11:g.162 717357_162916007du p | GRCh37.p13 | First Pass | NC_000006.11 | Chr6 | 162,717,357 | 162,916,007 |
| nssv649985 | Submitted genomic | NC_000006.10:g.162 637347_162835997du p | NCBI36 (hg18) | NC_000006.10 | Chr6 | 162,637,347 | 162,835,997 | ||
| nssv650309 | Submitted genomic | NC_000006.10:g.162 637347_162835997du p | NCBI36 (hg18) | NC_000006.10 | Chr6 | 162,637,347 | 162,835,997 |
No validation data were submitted for this variant
Clinical Assertions
| Variant Call ID | HGVS | Type | Subject Phenotype | Clinical Interpretation | Source of Interpretation |
|---|---|---|---|---|---|
| nssv649985 | NCBI36: NC_000006.10:g.162637347_162835997dup | duplication | Parkinsonian Disorders | Pathogenic | Submitter |
| nssv650309 | NCBI36: NC_000006.10:g.162637347_162835997dup | duplication | Neoplasms | Pathogenic | Submitter |